• Blood Centrifugation

    Sunstein prosecuted blood centrifugation patents for Haemonetics Corporation, a leader in the field of blood processing. The patented technologies allow blood components to be collected and processed for life-saving transfusions.

  • Purification

    Innovations by DEKA Research increase the efficiency of water purification systems, while reducing power and maintenance requirements. International patent applications like the one Sunstein prepared for DEKA can lead to worldwide adoption of a useful technology – one that can supply the developing world with access to safe water.

  • Shaft/hub

    Custom Machine & Tool Co. invented a novel shaft/hub connection device for precise component positioning and tight run-out control in demanding torque transmission applications such as timing-belt pulleys. Rigorous engineering analyses, as shown, demonstrate the benefits of CMT’s invention compared to other connection systems. The patent Sunstein obtained bolsters CMT’s position in a crowded marketplace.

  • Intravascular Stent

    Sunstein prosecuted a patent for a new stent that retains high radial strength but is more flexible and easier to insert into a patient’s coronary artery. The Crown™ stent is the product of our client DEKA’s collaboration with Cordis Corp., a Johnson & Johnson company, to improve the design of the Palmaz-Schatz® stent, the first intravascular stent proven to reduce blockage in arteries.

Juries. Patents. Success.

Comair Rotron, Inc. v Matsushita Electric Corp. of America

We obtained a $25 million judgment against industry giant Panasonic for willful infringement of our client Comair’s patents on fans for electronic equipment.

Exergen Corporation vs. Kaz, USA, Inc.

Sunstein lawyers won a $14.6M verdict for patent infringement following a two-week jury trial for our client Exergen, the people who pioneered the temporal artery thermometer.

Gates Formed-Fibre Products, Inc. v. Delaware Valley Corp.

By persuading a jury that the patents in suit were invalid, we successfully defended our client against accusations of infringement concerning a process for making fused-back automotive carpeting.

Winning at Post Grant Proceedings

Samsung Electronics Co., Ltd. v. Arendi  S.A.R.L.

Samsung attacked our client’s patent in the Patent Trial and Appeal Board (PTAB) on grounds of obviousness. We persuaded the PTAB that an element of the claims was not disclosed by the cited references and thus prevented the inter partes review from even being instituted.

Click here to learn more about Sunstein litigators.

 

Spotlight on Patents

A recent patent we obtained for our client Nexsan, of Santa Clara, CA,  U.S. Patent No. 9218406 covers a private cloud storage system in which security is maintained by storing the data on devices (sold under the Transporter brand) of  individual users.  Data is shared on a peer-to-peer basis.  A central  server governs access based on user privileges without storing any of  the shared data. This patent has issued in one of the fields in which recent court rulings have been propelling rapid evolution of the law.

In the News

Our Latest Thinking

  • Steven A. Abreu

    Parody protected: Louis Vuitton not only loses a trademark infringement suit against a canvas-tote maker that poked fun at the pricey bags but is faulted for lacking a sense of humor.

    More...

  • Brandon Scruggs

    No standing: A non-infringer who initiates an IPR may not be able to show sufficient stake in the outcome to appeal an adverse decision of the PTAB.

    More...

  • Nancy C. Wilker, Ph.D., J.D.W. John Keyes, Ph.D., J.D.

    Eleventh Amendment to the rescue: Sovereign immunity is ruled to protect state universities from having their patents challenged in the patent office.

    More...

  • Gozde Guckaya

    Supreme Court cheat sheet: Here’s a rundown of IP cases to be decided this term.

    More...

  • W. John Keyes, Ph.D., J.D.

    Sometimes, it takes a village to infringe a patent. The combination of doctors advising patients to take vitamins before chemotherapy and patients following that advice is held to infringe a method of administering a drug.

    More...

Free Subscription

See more in Publications/News